|4.75||0||0.00||Vol 62.95K||1Y Perf 58.19%|
|Apr 16th, 2021 10:57 DELAYED|
|- -%||- -|
|Target Price||6.50||Analyst Rating||— 0.00|
|Potential %||36.84||Finscreener Ranking||★★★★★ — -|
|Insiders Trans % 3/6/12 mo.||-/-/-||Value Ranking||★★★★★ 72.60|
|Insiders Value % 3/6/12 mo.||-/-/-||Growth Ranking||★★★★★ 79.12|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-/-||Income Ranking||★★★★+ — -|
|Market Cap||577.37M||Earnings Rating||Buy|
|Price Range Ratio 52W %||90.57||Earnings Date||24th Feb 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||-|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||248.62K|
|Avg. Monthly Volume||163.53K|
|Avg. Quarterly Volume||273.64K|
Global Cord Blood Corporation (NYSE: CO) stock closed at 4.75 per share at the end of the most recent trading day (a -0.42% change compared to the prior day closing price) with a volume of 403.90K shares and market capitalization of 577.37M. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 1260 people. Global Cord Blood Corporation CEO is Ting Zheng.
The one-year performance of Global Cord Blood Corporation stock is 58.19%, while year-to-date (YTD) performance is 28.03%. CO stock has a five-year performance of -24.48%. Its 52-week range is between 2.54 and 4.98, which gives CO stock a 52-week price range ratio of 90.57%
Global Cord Blood Corporation currently has a PE ratio of 8.20, a price-to-book (PB) ratio of 0.86, a price-to-sale (PS) ratio of 4.40, a price to cashflow ratio of 7.00, a PEG ratio of 2.32, a ROA of 6.39%, a ROC of 11.28% and a ROE of 11.78%. The company’s profit margin is 45.01%, its EBITDA margin is 48.90%, and its revenue ttm is $131.24 Million , which makes it $1.08 revenue per share.
Of the last four earnings reports from Global Cord Blood Corporation, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Global Cord Blood Corporation’s next earnings report date is -.
The consensus rating of Wall Street analysts for Global Cord Blood Corporation is — (0), with a target price of $6.5, which is +36.84% compared to the current price. The earnings rating for Global Cord Blood Corporation stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Global Cord Blood Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of 20.00%.
Global Cord Blood Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 12.15, ATR14 : 0.24, CCI20 : 131.30, Chaikin Money Flow : 0.26, MACD : 0.15, Money Flow Index : 53.94, ROC : 3.49, RSI : 54.36, STOCH (14,3) : 86.49, STOCH RSI : 0.13, UO : 70.69, Williams %R : -13.51), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Global Cord Blood Corporation in the last 12-months were:
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.